Skip to Content
Merck
CN
All Photos(1)

Documents

5000

Sigma-Aldrich

Oxaloacetic Acid - CAS 328-42-7 - Calbiochem

Substrate for malate dehydrogenase and oxaloacetate decarboxylase.

Sign Into View Organizational & Contract Pricing

Synonym(s):
Oxaloacetic Acid - CAS 328-42-7 - Calbiochem, OAA
Empirical Formula (Hill Notation):
C4H4O5
CAS Number:
Molecular Weight:
132.07
MDL number:
UNSPSC Code:
12352200

Quality Level

Assay

>98% (titration)

form

solid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze

color

white to off-white

solubility

water: soluble

shipped in

ambient

storage temp.

2-8°C

InChI

1S/C4H4O5/c5-2(4(8)9)1-3(6)7/h1H2,(H,6,7)(H,8,9)

InChI key

KHPXUQMNIQBQEV-UHFFFAOYSA-N

General description

Substrate for malate dehydrogenase and oxalacetate decarboxylase.
Substrate for malate dehydrogenase and oxaloacetate decarboxylase.

Warning

Toxicity: Corrosive (L)

Reconstitution

Following reconstitution, refrigerate (4°C).

Other Notes

Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
Flint, D.H. 1993. Biochemistry 32, 799.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Eye Irrit. 2

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ryoki Nakamura et al.
Communications biology, 3(1), 240-240 (2020-05-18)
Members of the leucine-rich repeat-containing 8 (LRRC8) protein family, composed of the five LRRC8A-E isoforms, are pore-forming components of the volume-regulated anion channel (VRAC). LRRC8A and at least one of the other LRRC8 isoforms assemble into heteromers to generate VRAC
Takeshi Yoshida et al.
Frontiers in cell and developmental biology, 7, 316-316 (2019-12-19)
Infantile-onset Pompe disease (IOPD) is a life-threatening multi-organ disease caused by an inborn defect of lysosomal acid α-glucosidase (GAA), which can degrade glycogen into glucose. Lack of GAA causes abnormal accumulation of glycogen in the lysosomes, particularly in the skeletal
Hiroyuki Kabayama et al.
Nature communications, 11(1), 336-336 (2020-01-19)
Targeting cytoplasmic protein-protein interactions with antibodies remains technically challenging, since antibodies expressed in the cytosol frequently form insoluble aggregates. Existing engineering methods are based on the notion that the estimated net charge at pH 7.4 affects stability; as such, they
Heather C Rice et al.
Molecular neurodegeneration, 15(1), 3-3 (2020-01-10)
The amyloid-β (Aβ) peptide, the primary constituent of amyloid plaques found in Alzheimer's disease (AD) brains, is derived from sequential proteolytic processing of the Amyloid Precursor Protein (APP). However, the contribution of different cell types to Aβ deposition has not
Nabila Haji et al.
Molecular autism, 11(1), 29-29 (2020-05-08)
Mutations in TSC1 or TSC2 genes cause tuberous sclerosis complex (TSC), a disorder associated with epilepsy, autism, and intellectual disability. TSC1 and TSC2 are repressors of the mechanistic target of rapamycin complex 1 (mTORC1), a key regulator of protein synthesis.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service